Udemy Inc header image

Udemy Inc

UDMY

Equity

ISIN null / Valor 114176816

NASDAQ (2025-11-17)
USD 4.92-5.02%

Udemy Inc
UMushroom community rating:

star star star star star
4.00 1 votes No rating yet
NegativeNeutralPositive

About company

Udemy Inc. is a global online learning platform offering a wide range of courses taught by expert instructors, catering to both professional development and personal interests.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results (10.10.2025):

Udemy Inc. reported its financial results for the fourth quarter of 2024, showcasing a robust performance with significant growth in enterprise revenue and substantial improvements in profitability metrics compared to the same period in 2023.

Total Revenue Growth

For the fourth quarter of 2024, Udemy Inc. achieved total revenue of $199.9 million, marking a 5% year-over-year increase. On a full-year basis, revenue grew by 8% to $786.6 million, despite a 2 percentage point negative impact from foreign exchange rates.

Enterprise Segment Performance

The Enterprise segment, also known as Udemy Business, saw its quarterly revenue rise by 13% year-over-year to $130.1 million. For the full year, Enterprise revenue surged by 18% to $494.5 million, demonstrating strong demand and market expansion.

Consumer Segment Revenue

In contrast, the Consumer segment experienced a decline, with quarterly revenue decreasing by 7% year-over-year to $69.8 million. For the full year, Consumer revenue fell by 5% to $292.1 million, influenced by similar foreign exchange headwinds.

Profitability and EBITDA

Udemy Inc. reported an Adjusted EBITDA of $19.5 million for the fourth quarter 2024, a significant increase of 390% compared to $4.0 million in the same quarter last year. The Adjusted EBITDA margin improved to 10% from 2% year-over-year. For the full year, Adjusted EBITDA reached $43.0 million, up 451% from $7.8 million in 2023.

Net Loss Reduction

The company reduced its net loss to $(9.9) million for the fourth quarter of 2024, a 51% improvement compared to $(20.2) million in the fourth quarter of 2023. On a full-year basis, net loss stood at $(85.3) million, narrowing by 21% from $(107.3) million the previous year.

Summarized from source with an LLMView Source

Key figures

-38.2%1Y
-65.7%3Y
%5Y

Performance

57.3%1Y
53.6%3Y
58.9%5Y

Volatility

Market cap

740 M

Market cap (USD)

Daily traded volume (Shares)

2,595,269

Daily traded volume (Shares)

1 day high/low

8.12 / 7.805

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

4.00

1 votes
Performance:
starstarstarstarstar
3.00
Innovation:
starstarstarstarstar
3.00
Society:
starstarstarstarstar
4.00
Nature:
starstarstarstarstar
4.00
Atanas WI Atanasov
United Kingdom, 17 Feb 2025
star star star star star
Education is always a valuable asset. It’s great to see this company making learning more accessible through discounted courses.

EQUITIES OF THE SAME SECTOR

Bio-Rad Laboratories, Inc. Class B
Bio-Rad Laboratories, Inc. Class B Bio-Rad Laboratories, Inc. Class B Valor: 912794
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.18%USD 310.70
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.81%USD 88.40
Inspire Medical Systems Inc
Inspire Medical Systems Inc Inspire Medical Systems Inc Valor: 41329373
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.71%USD 84.87
agilon health inc
agilon health inc agilon health inc Valor: 110653729
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-6.75%USD 0.54
Helen of Troy Ltd
Helen of Troy Ltd Helen of Troy Ltd Valor: 938381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.14%USD 17.55
M1 Kliniken AG
M1 Kliniken AG M1 Kliniken AG Valor: 29694419
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.71%EUR 15.54
STERIS PLC
STERIS PLC STERIS PLC Valor: 47027903
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 257.01
Perrigo Company PLC
Perrigo Company PLC Perrigo Company PLC Valor: 22008864
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.60%USD 13.56
Evolent Health Inc
Evolent Health Inc Evolent Health Inc Valor: 28153126
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-7.42%USD 3.87
Pfizer Inc
Pfizer Inc Pfizer Inc Valor: 962004
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.08%USD 25.08